Annual CFO
-$22.30 M
+$3.50 M+13.58%
31 December 2023
Summary:
Profound Medical annual cash flow from operations is currently -$22.30 million, with the most recent change of +$3.50 million (+13.58%) on 31 December 2023. During the last 3 years, it has fallen by -$1.72 million (-8.37%). PROF annual CFO is now -351.03% below its all-time high of -$4.94 million, reached on 31 December 2015.PROF Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$6.36 M
-$13.00 K-0.20%
01 September 2024
Summary:
Profound Medical quarterly cash flow from operations is currently -$6.36 million, with the most recent change of -$13.00 thousand (-0.20%) on 01 September 2024. Over the past year, it has dropped by -$2.02 million (-46.68%). PROF quarterly CFO is now -16090.84% below its all-time high of -$39.30 thousand, reached on 31 March 2015.PROF Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$24.83 M
-$2.02 M-8.88%
01 September 2024
Summary:
Profound Medical TTM cash flow from operations is currently -$24.83 million, with the most recent change of -$2.02 million (-8.88%) on 01 September 2024. Over the past year, it has dropped by -$2.93 million (-13.38%). PROF TTM CFO is now -63075.57% below its all-time high of -$39.30 thousand, reached on 31 March 2015.PROF TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PROF Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.6% | -46.7% | -13.4% |
| 3 y3 years | -8.4% | -26.8% | -0.3% |
| 5 y5 years | -66.0% | -159.6% | -101.1% |
PROF Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -8.4% | +13.6% | -46.7% | +19.0% | -15.1% | +3.8% |
| 5 y | 5 years | -66.0% | +13.6% | -286.6% | +19.0% | -101.1% | +3.8% |
| alltime | all time | -351.0% | +13.6% | <-9999.0% | +19.0% | <-9999.0% | +3.8% |
Profound Medical Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.36 M(+0.2%) | -$24.83 M(+8.9%) |
| June 2024 | - | -$6.35 M(+24.6%) | -$22.80 M(+5.7%) |
| Mar 2024 | - | -$5.10 M(-27.3%) | -$21.57 M(-3.3%) |
| Dec 2023 | -$22.30 M(-13.6%) | -$7.02 M(+61.8%) | -$22.30 M(+1.8%) |
| Sept 2023 | - | -$4.34 M(-15.3%) | -$21.90 M(-6.1%) |
| June 2023 | - | -$5.12 M(-12.1%) | -$23.32 M(-1.9%) |
| Mar 2023 | - | -$5.82 M(-12.0%) | -$23.76 M(-7.9%) |
| Dec 2022 | -$25.80 M(+15.4%) | -$6.62 M(+15.0%) | -$25.80 M(+6.5%) |
| Sept 2022 | - | -$5.75 M(+3.4%) | -$24.23 M(+3.1%) |
| June 2022 | - | -$5.57 M(-29.2%) | -$23.50 M(-1.9%) |
| Mar 2022 | - | -$7.86 M(+55.5%) | -$23.95 M(+7.1%) |
| Dec 2021 | -$22.36 M(+8.7%) | -$5.05 M(+0.7%) | -$22.36 M(-9.7%) |
| Sept 2021 | - | -$5.02 M(-16.6%) | -$24.75 M(+3.0%) |
| June 2021 | - | -$6.02 M(-4.1%) | -$24.04 M(+22.2%) |
| Mar 2021 | - | -$6.27 M(-15.8%) | -$19.66 M(-4.4%) |
| Dec 2020 | -$20.57 M(+36.7%) | -$7.45 M(+73.1%) | -$20.57 M(+11.3%) |
| Sept 2020 | - | -$4.30 M(+161.3%) | -$18.49 M(+11.1%) |
| June 2020 | - | -$1.65 M(-77.1%) | -$16.64 M(-16.1%) |
| Mar 2020 | - | -$7.18 M(+34.0%) | -$19.82 M(+31.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$15.05 M(+12.0%) | -$5.36 M(+118.6%) | -$15.05 M(+21.9%) |
| Sept 2019 | - | -$2.45 M(-49.2%) | -$12.35 M(-10.1%) |
| June 2019 | - | -$4.83 M(+100.4%) | -$13.73 M(+5.9%) |
| Mar 2019 | - | -$2.41 M(-9.2%) | -$12.96 M(-3.5%) |
| Dec 2018 | -$13.43 M(+13.7%) | -$2.65 M(-30.7%) | -$13.43 M(-6.1%) |
| Sept 2018 | - | -$3.83 M(-5.8%) | -$14.31 M(+12.8%) |
| June 2018 | - | -$4.06 M(+41.1%) | -$12.68 M(+7.5%) |
| Mar 2018 | - | -$2.88 M(-18.4%) | -$11.79 M(-0.2%) |
| Dec 2017 | -$11.81 M(+9.5%) | -$3.53 M(+60.3%) | -$11.81 M(+1.2%) |
| Sept 2017 | - | -$2.20 M(-30.7%) | -$11.68 M(+1.6%) |
| June 2017 | - | -$3.18 M(+9.6%) | -$11.49 M(+2.6%) |
| Mar 2017 | - | -$2.90 M(-14.6%) | -$11.21 M(+3.9%) |
| Dec 2016 | -$10.79 M(+118.3%) | -$3.39 M(+68.0%) | -$10.79 M(+27.7%) |
| Sept 2016 | - | -$2.02 M(-30.1%) | -$8.45 M(+6.1%) |
| June 2016 | - | -$2.89 M(+16.4%) | -$7.96 M(+7.7%) |
| Mar 2016 | - | -$2.48 M(+136.2%) | -$7.39 M(+49.4%) |
| Dec 2015 | -$4.94 M | -$1.05 M(-31.4%) | -$4.94 M(+27.0%) |
| Sept 2015 | - | -$1.53 M(-34.0%) | -$3.89 M(+64.9%) |
| June 2015 | - | -$2.32 M(+5808.1%) | -$2.36 M(+5908.1%) |
| Mar 2015 | - | -$39.30 K | -$39.30 K |
FAQ
- What is Profound Medical annual cash flow from operations?
- What is the all time high annual CFO for Profound Medical?
- What is Profound Medical annual CFO year-on-year change?
- What is Profound Medical quarterly cash flow from operations?
- What is the all time high quarterly CFO for Profound Medical?
- What is Profound Medical quarterly CFO year-on-year change?
- What is Profound Medical TTM cash flow from operations?
- What is the all time high TTM CFO for Profound Medical?
- What is Profound Medical TTM CFO year-on-year change?
What is Profound Medical annual cash flow from operations?
The current annual CFO of PROF is -$22.30 M
What is the all time high annual CFO for Profound Medical?
Profound Medical all-time high annual cash flow from operations is -$4.94 M
What is Profound Medical annual CFO year-on-year change?
Over the past year, PROF annual cash flow from operations has changed by +$3.50 M (+13.58%)
What is Profound Medical quarterly cash flow from operations?
The current quarterly CFO of PROF is -$6.36 M
What is the all time high quarterly CFO for Profound Medical?
Profound Medical all-time high quarterly cash flow from operations is -$39.30 K
What is Profound Medical quarterly CFO year-on-year change?
Over the past year, PROF quarterly cash flow from operations has changed by -$2.02 M (-46.68%)
What is Profound Medical TTM cash flow from operations?
The current TTM CFO of PROF is -$24.83 M
What is the all time high TTM CFO for Profound Medical?
Profound Medical all-time high TTM cash flow from operations is -$39.30 K
What is Profound Medical TTM CFO year-on-year change?
Over the past year, PROF TTM cash flow from operations has changed by -$2.93 M (-13.38%)